Can a new imaging trick spot pancreatic cancer without a biopsy?

NCT ID NCT07763561

Not yet recruiting Diagnosis Sponsor: Julio Iglesias García Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study looks at whether a special ultrasound technique called detective flow imaging (DFI) can help doctors tell the difference between benign and malignant solid pancreatic lesions. Researchers will examine the blood vessel patterns seen with this technique and compare them to the final diagnosis from tissue samples or follow-up. The study involves 48 adults with solid pancreatic lesions and aims to see if this imaging method is accurate and consistent between different doctors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Endoscopic ultrasound-guided detective flow imaging (EUS-DFI), an imaging technique
What this could lead to: If successful, this imaging method could improve how doctors tell benign from malignant pancreatic lesions without invasive biopsies, leading to faster and more accurate diagnoses.
What could go wrong: This is an observational study with a small number of participants, so results may not apply broadly. The technique's accuracy depends on operator skill, and it may not clearly distinguish all tumor types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC NEOPLASMS PANCREATIC SOLID LESIONS

More trials for these conditions

Other studies related to the condition(s) this trial covers.